Podcast: Perspectives and projections on the 2025 biotech landscape
The biotech industry is experiencing an unprecedented transformation, marked by complex market dynamics, shifting global innovation patterns and evolving investment…
Partner Content
-
-
Unmatched quality in pharmaceutical logistics: Why it matters
Ensuring the integrity of pharmaceutical products is one of the most complex challenges in global healthcare today. From temperature-sensitive biologics…
-
Early access programs for rare disease drugs in Europe: What you need to know
We’ve all seen the statistics – over 7,000 rare diseases, and only 5% have any approved treatments. It’s a situation…
-
Mastering compliance and copyright in healthcare and MedComms
In a recent webinar, Marc McArdle, CLA Customer Success Manager, was joined by Jackie Marchington, Head of Compliance and Ethics…
-
Navigating the triple-negative breast cancer global clinical trial landscape in 2025
A new report from leading global contract research organization Novotech examines the triple-negative breast cancer global clinical trial landscape in…
-
The future of eClinical technology interoperability: Have your say
Today’s clinical landscape is increasingly data-driven, and technology interoperability is critical for advancing research and improving outcomes. But what demands…
-
Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers
The market for clinical trials in China is currently experiencing significant growth, driven by increasing activity from both Chinese sponsors…
-
Artificial intelligence is making clinical supply chains more efficient and more sustainable: here’s how
The pharmaceutical industry is in the midst of a digital revolution; technology investments and data-driven decision-making are constantly on the…
-
Project Optimus: The evolution of dose optimisation in oncology
In 2021, the Project Optimus initiative was launched by the US Food and Drug Administration’s (FDA) Oncology Center of Excellence,…
-
Beyond compliance: The strategic role of PASS in rare disease therapy success
By taking a more strategic approach to PASS, you can secure long-term market access, gain regulatory trust, and provide critical…
